Literature DB >> 10432512

Synaptic contacts in schizophrenia: studies using immunocytochemical identification of dopaminergic neurons.

N S Kolomeets1, N A Uranova.   

Abstract

Immunocytochemical identification of dopaminergic neurons was performed using an immunoperoxidase method employing antibodies to tyrosine hydroxylase. The ultrastructure of synaptic contacts on dopaminergic (tyrosine hydroxylase immunopositive (TP) cells) neurons was investigated in the substantia nigra in the brains of four patients with schizophrenia and three mentally healthy subjects (controls). The substantia nigra of schizophrenia patients differed from control material in showing the following changes in the ultrastructure of presynaptic terminals contacting TP neurons: reductions in the size of terminals with dense matrix and poorly distinguished vesicles; swelling of terminals with small numbers of vesicles displaced from the active zone of the synapse; hyperplasia of mitochondria in some presynaptic boutons; appearance of membranous lamellar structures within or adjacent to presynaptic boutons. These changes to terminals were located mostly on the distal (small and intermediate) TP dendrites in the compact zone of the substantia nigra, where nearly all the dendrites detected belonged to dopaminergic neurons and the altered terminals formed asymmetrical contacts with short active zones. In the reticular part of the substantia nigra of schizophrenic patients, changes in the ultrastructure of presynaptic terminals were relatively rare; altered terminals contacted both tyrosine hydroxylase immunopositive as well as with the tyrosine hydroxylase immunonegative dendrites located in this structure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432512     DOI: 10.1007/bf02465329

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  19 in total

Review 1.  Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

Authors:  M Carlsson; A Carlsson
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

2.  Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients.

Authors:  F M Benes; J McSparren; E D Bird; J P SanGiovanni; S L Vincent
Journal:  Arch Gen Psychiatry       Date:  1991-11

3.  [Ultrastructure of the substantia nigra in schizophrenia].

Authors:  N A Uranova; O I Levité
Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova       Date:  1987

4.  Quantitative cytoarchitectonics of the human cerebral cortex in schizophrenic dementia.

Authors:  E J Colon
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

5.  Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics.

Authors:  F M Benes; J Davidson; E D Bird
Journal:  Arch Gen Psychiatry       Date:  1986-01

6.  Effects of frontal motor cortex ablation on the ultrastructure of cat substantia nigra.

Authors:  C Nitsch; K Mews; A Wagner; R Hassler
Journal:  Acta Anat (Basel)       Date:  1984

Review 7.  Dopamine in schizophrenia: a review and reconceptualization.

Authors:  K L Davis; R S Kahn; G Ko; M Davidson
Journal:  Am J Psychiatry       Date:  1991-11       Impact factor: 18.112

8.  Positive and negative schizophrenia symptoms and the role of dopamine.

Authors:  T J Crow
Journal:  Br J Psychiatry       Date:  1981-09       Impact factor: 9.319

9.  The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat.

Authors:  J P Bolam; Y Smith
Journal:  Brain Res       Date:  1990-10-08       Impact factor: 3.252

10.  GABAergic synaptic interactions in the substantia nigra.

Authors:  I Mendez; K Elisevich; B A Flumerfelt
Journal:  Brain Res       Date:  1993-07-23       Impact factor: 3.252

View more
  13 in total

Review 1.  Postmortem studies on mitochondria in schizophrenia.

Authors:  Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2017-02-09       Impact factor: 4.939

2.  Ultrastructural evidence for glutamatergic dysregulation in schizophrenia.

Authors:  Rosalinda C Roberts; Lesley A McCollum; Kirsten E Schoonover; Samuel J Mabry; Joy K Roche; Adrienne C Lahti
Journal:  Schizophr Res       Date:  2020-01-31       Impact factor: 4.939

3.  Sex and laterality differences in parkinsonian impairment and transcranial ultrasound in never-treated schizophrenics and their first degree relatives in an Andean population.

Authors:  Danielle Kamis; Lee Stratton; María Calvó; Eduardo Padilla; Néstor Florenzano; Gonzalo Guerrero; Beatriz Molina Rangeon; Juan Molina; Gabriel A de Erausquin
Journal:  Schizophr Res       Date:  2015-02-27       Impact factor: 4.939

Review 4.  Impaired mitochondrial function in psychiatric disorders.

Authors:  Husseini Manji; Tadafumi Kato; Nicholas A Di Prospero; Seth Ness; M Flint Beal; Michael Krams; Guang Chen
Journal:  Nat Rev Neurosci       Date:  2012-04-18       Impact factor: 34.870

5.  Evidence for altered excitatory and inhibitory tone in the post-mortem substantia nigra in schizophrenia.

Authors:  Samuel J Mabry; Lesley A McCollum; Charlene B Farmer; Emma S Bloom; Rosalinda C Roberts
Journal:  World J Biol Psychiatry       Date:  2019-06-04       Impact factor: 4.132

Review 6.  Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.

Authors:  Emma Perez-Costas; Miguel Melendez-Ferro; Rosalinda C Roberts
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

7.  The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia.

Authors:  Dorit Ben-Shachar
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

Review 8.  Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms.

Authors:  Ryan J Van Lieshout; Lakshmi P Voruganti
Journal:  J Psychiatry Neurosci       Date:  2008-09       Impact factor: 6.186

9.  Serotonergic hyperinnervation and effective serotonin blockade in an FGF receptor developmental model of psychosis.

Authors:  Ilona Klejbor; Aaron Kucinski; Scott R Wersinger; Thomas Corso; Jan H Spodnik; Jerzy Dziewiatkowski; Janusz Moryś; Renae A Hesse; Kenner C Rice; Robert Miletich; Ewa K Stachowiak; Michal K Stachowiak
Journal:  Schizophr Res       Date:  2009-07-01       Impact factor: 4.939

10.  Mitochondrial dysfunction in schizophrenia: With a focus on postmortem studies.

Authors:  Rosalinda C Roberts
Journal:  Mitochondrion       Date:  2020-11-20       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.